PERGOLIDE IN THE TREATMENT OF PARKINSONS-DISEASE

被引：2
作者：
ROBIN, DW
机构：
[1] Div. of Clinical Pharmacology, Department of Pharmacology, Vanderbilt Univ. Sch. of Med., Nashville
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1991年 / 301卷 / 04期
关键词：
D O I：
10.1097/00000441-199104000-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：277 / 280
页数：4
相关论文
共 24 条
[21]   LONG-TERM EFFICACY OF PERGOLIDE IN PATIENTS WITH PARKINSONS-DISEASE [J].
SAGE, JI ;
DUVOISIN, RC .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :160-164
[22]   PERGOLIDE MESYLATE - LACK OF CARDIAC TOXICITY IN PATIENTS WITH CARDIAC DISEASE [J].
TANNER, CM ;
CHHABLANI, R ;
GOETZ, CG ;
KLAWANS, HL .
NEUROLOGY, 1985, 35 (06) :918-921
[23]  
TANNER CM, 1986, ADV NEUROL, V45, P547
[24]   BROMOCRIPTINE, SELECTIVE D2 DOPAMINE RECEPTOR AGONISTS AND D1 DOPAMINERGIC TONE [J].
WADDINGTON, JL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (06) :223-224
123